Clynne Marle M Sedel 8n2u SepLember 13 2011

NAML CI DkUG INDICA1ICNS DCSAGL AC1ICNS CCN1kAINDICA1

ICN
ADVLkSL IkLL
AC1ICN
IN1LkAC1ICN NUkSING
kLSCNSI8ILI1LS

16Nklc
N4M
MetbylJopo


8k4Nu
N4M
AlJomet


























lor susLalned
mlld Lo severe
hyperLensLlon
























230 mg / Lab
1Lab

kCU1L
8lu

































lnhlblLs Lhe
cenLral
vasomoLor
cenLers Lhereby
decreaslng
sympaLheLlc
ouLflow






























Should noL be
used for acuLe
LreaLmenL of
hyperLenslve
emergencles

































8|ood
PemolyLlc
anemla
reverslble
granulocyLopenla
Lhrombo
cyLopenla
CNS
SedaLlon
headache
asLhenla
weakness
dlzzlness
decreased
menLal aqulLy
CV
8radycardla
orLhosLaLlc
hypoLensLlon
aggravaLed aglna
LLN1
ury mouLh nasal
sLufflness
GI
dlarrhea
nepat|c
PepaLlc necrosls





Levodopa
addlLlve
hypoLneslve
effecLs posslble
lncreased CnS
adverse
reacLlons

NCrep|nephr|ne
phenoth|az|nes
tr|cyc||c
ant|depressants
posslble
hyperLenslve
effecLs
MonlLor carefully
















use cauLlously ln
paLlenLs recelvlng
oLher
anLlhyperLenslves
or MAC lnhlblLors
and ln paLlenLs
wlLh lmpalred
hepaLlc funcLlons
MonlLor blood
pressure and pulse
raLe frequenLly

observe for
lnvolunLary
choreoaLheLold
movemenLs
8eporL Lo docLor
he may
dlsconLlnue drug

lf paLlenL requlre
blood Lransfuslon
make sure he geLs
dlrecL and lndlrecL
Coombs' LesL Lo
avold cross
maLchlng
problems






Clynne Marle M Sedel 8n2u SepLember 13 2011




26Nklc
N4M
Amoxlcllllo/clovo
loolc oclJ
(coomoxlclov)

8k4Nu N4M
Aoqmeotlo
Amocloo co
omoxlclov
clovomox
Nottovox

cL455
leolcllllos



Upper
resp|ratory tract
|nfect|ons
(|nc|ud|ng LN1)
slnuslLls oLlLls
medla recurrenL
LonsllllLls
Lower
resp|ratory tract
|nfect|onsacuLe
exacerbaLlons of
chronlc
bronchlLls
bronchopneumo
nla urlnaryLracL
lnfecLlons
Gen|tour|nary
tract and
abdom|na|
|nfect|ons ln
parLlcular cysLlLls
sepLlc aborLlon
pelvlc or
puerperal sepsls
and lnLra
abdomlnal
sepsls






623mg/ Lab


kCU1L
C 8 P



An
amlnopenlclllln
LhaL acLs by
prevenLlng
bacLerlal wall
synLhesls durlng
acLlve
repllcaLlon
Clavulanlc acld
lncrease
amoxlclllln
effecLlveness by
lnacLlvaLlng beLa
lacLameses
whlch desLroy
amoxlclllln



Coamoxlclav ls
conLralndlcaLed
ln paLlenLs wlLh a
hlsLory of allerglc
reacLlons Lo any
penlclllln lL ls
also
conLralndlcaLed
ln paLlenLs wlLh a
prevlous hlsLory
of amoxlclllln
poLasslum
clavulanaLe
assoclaLed
cholesLaLlc
[aundlce/ hepaLlc
dysfuncLlon


8|ood
Anemla
Lhrombo
cyLopenla
Lhrombo
cyLopenlc
purpura
eoslnophllla
leucopenla
GI
nausea
vomlLlng
dlarrhea
Cthers
PypersenslLlvlLy






A||opur|no|
lncreased
lncldence of skln
rash
robenec|d
lncrease blood
levels of
amoxlclllln and
oLher penlcllllns
robenecld may
be used for Lhls
purpose
Assess bowel
paLLern before
and durlng
LreaLmenL as
pseudomembra
nous collLls may
occur
8eporL
haemaLurla or
ollgurla as hlgh
doses can be
nephroLoxlc
Assess
resplraLory
sLaLus
Cbserve for
anaphylaxls
Lnsure LhaL
Lhe paLlenL has
adequaLe fluld
lnLake durlng
any dlarrhoea
aLLack